Chlorine in PDB 6frx: Pka Variant As Aurora B Mimic in Complex with A Dianilinopyrimidine Inhibitor

All present enzymatic activity of Pka Variant As Aurora B Mimic in Complex with A Dianilinopyrimidine Inhibitor:
2.7.11.11;

The structure of Pka Variant As Aurora B Mimic in Complex with A Dianilinopyrimidine Inhibitor, PDB code: 6frx was solved by R.A.Engh, A.A.Kazi, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	46.90 / 1.88
Space group	P 21 21 21
Cell size a, b, c (Å), α, β, γ (°)	58.743, 77.784, 96.484, 90.00, 90.00, 90.00
R / Rfree (%)	19 / 22.6

The binding sites of Chlorine atom in the Pka Variant As Aurora B Mimic in Complex with A Dianilinopyrimidine Inhibitor (pdb code 6frx). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Pka Variant As Aurora B Mimic in Complex with A Dianilinopyrimidine Inhibitor, PDB code: 6frx:

Chlorine binding site 1 out of 1 in the Pka Variant As Aurora B Mimic in Complex with A Dianilinopyrimidine Inhibitor


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Pka Variant As Aurora B Mimic in Complex with A Dianilinopyrimidine Inhibitor within 5.0Å range: probe atom residue distance (Å) B Occ A:Cl401 b:38.2 occ:1.00 CL5 A:E3Z401 0.0 38.2 1.0 C5 A:E3Z401 1.7 32.6 1.0 C6 A:E3Z401 2.7 27.6 1.0 C4 A:E3Z401 2.7 33.6 1.0 NAO A:E3Z401 2.9 31.7 1.0 O A:HOH653 3.2 35.1 1.0 CD1 A:LEU120 3.7 29.0 1.0 CB A:ALA70 3.8 25.6 1.0 CB A:LEU120 3.9 27.4 1.0 N1 A:E3Z401 4.0 27.9 1.0 N3 A:E3Z401 4.0 31.9 1.0 O A:HOH690 4.0 40.3 1.0 CD1 A:LEU173 4.0 29.8 1.0 CG1 A:VAL104 4.1 30.1 1.0 O A:GLU121 4.2 26.6 1.0 CAP A:E3Z401 4.3 35.3 1.0 CB A:ALA183 4.3 27.7 1.0 CG A:LEU120 4.4 33.7 1.0 C2 A:E3Z401 4.5 26.4 1.0 CG2 A:VAL104 4.7 28.9 1.0 CB A:VAL104 4.9 27.6 1.0 CG1 A:VAL57 4.9 27.4 1.0 CAU A:E3Z401 5.0 35.2 1.0

R.A.Engh, A.A.Kazi. Pka Variant As Aurora B Mimic in Complex with A Dianilinopyrimidine Inhibitor To Be Published.